FindTrial
Sign In

A STUDY TO COMPARE THE BLOOD LEVELS OF VITAMIN D AND INTERLEUKIN 17(AN INFLAMMATORY MARKER)IN VITILIGO PATIENTS AND NORMAL HEALTHY INDIVIDUALS

SERUM LEVELS OF INTERLEUKIN 17 AND 25 HYDROXY VITAMIN D IN NONSEGMENTAL VITILIGO PATIENTS:A CASE CONTROL STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/09/027620
Enrollment
60
Registered
2020-09-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

None listed

Sponsors

DR ANJU GEORGE C
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult ( >18 years of age) patients of nonsegmental vitiligo seen in department of Dermatology, All India Institute of Medical Sciences, Raipur

Exclusion criteria

Exclusion criteria: 1. Patients who had received systemic therapy for vitiligo in past 2 months 2. Those who have taken vitamin D supplements in last one year 3. Patients who had received phototherapy in last 3 months 4. Patients with other autoimmune diseases 5. Patients with chronic inflammatory diseases 6. Patients with severe anemia 7. Pregnant women and lactating mothers. 8. Patients who are not willing to participate

Design outcomes

Primary

MeasureTime frame
Serum levels of interleukin 17 and 25- hydroxy vitamin D in nonsegmental vitiligo patients and healthy controlsTimepoint: FIRST POINT OF VISIT—

Secondary

MeasureTime frame
RELATION OF SERUM LEVELS OF INTERLEUKIN 17 AND 25 HYDROXY VITAMIN D WITH VITILIGO EXTENT AND ACTIVITYTimepoint: DURING ANALYSIS—

Countries

India

Contacts

Public ContactDR NAMRATA CHHABRA

ALL INDIA INSTITUTE OF MEDICAL SCIENCES,RAIPUR

anjuanne21@gmail.com9348113237

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026